Protagen Raises $12.7M to Support Protein Array Diagnostic Development
September 07, 2010
Protagen Raises $12.7M to Support Protein Array Diagnostic Development
The company said it will use the proceeds to expand its diagnostics business unit and to develop serum-based assays for the early detection of multiple sclerosis and prostate cancer.
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.